No Data
Hong Kong stocks fluctuate | Conic Jerry Pharmaceuticals-B (09966) soared more than 40%. HER2 dual-antibody ADC authorized cspc pharma. Involving a staggering 3.08 billion yuan investment.
Kangning Jeri Pharmaceuticals - B (09966) skyrocketed by over 40%, as of the press time, rose by 34.31%, trading at 4.11 Hong Kong dollars, with a turnover of 14.1032 million Hong Kong dollars.
CSPC Pharma (01093) has signed an exclusive licensing agreement with Jiangsu Kangning JieRui for the development and commercialization of JSKN003 in mainland China.
CSPC Pharma (01093) announced that its wholly-owned subsidiary, Shanghai Jinmantech Biotechnology Co., Ltd. (Jinmantech Biotech), has entered into an exclusive licensing agreement with Jiangsu Conray Biopharma Co., Ltd. (Jiangsu Conray) on September 29, 2024.
Express News | CSPC Pharmaceutical - License Agreement for Development & Commercialization of Jskn003 in Mainland China
Express News | CSPC Pharmaceutical - Exclusive License Agreement With Jiangsu Alphamab
cspc pharma [01093] is now trading at 5.18 Hong Kong dollars, with a rise of 5.07%.
As of 11:17, cspc pharma [01093] reported 5.18 Hong Kong dollars, up 0.25 Hong Kong dollars or 5.07% from the previous closing price of 4.93 Hong Kong dollars, with a turnover of 327.984 million Hong Kong dollars. The highest price today was 5.18 Hong Kong dollars, and the lowest price was 5.01 Hong Kong dollars. Based on yesterday's closing price calculation, the 10-day average price is 6.65 Hong Kong dollars, and the 50-day average price is 6.40 Hong Kong dollars. The current pe ratio is 12.64 times, and the 14-day relative strength index is 53.42.
Hong Kong stocks unusual movement | cspc pharma (01093) rose by over 4% again, blood pressure lowering drug approved to conduct clinical trials. The company recently announced a 5 billion Hong Kong dollar buyback plan.
cspc pharma (01093) rose more than 4% again, as of press time, up by 4.26%, at 5.14 Hong Kong dollars, with a turnover of 0.293 billion Hong Kong dollars.
No Data
No Data
